azides has been researched along with carboplatin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ling, V; Rischin, D | 1 |
| Aboagye, EO; Fortt, R; Fortt, RR; Witney, TH | 1 |
| Cheung, S; Griffith, DM; Kitteringham, E; O'Shea, DF; Twamley, B; Wu, D | 1 |
3 other study(ies) available for azides and carboplatin
| Article | Year |
|---|---|
Ormaplatin resistance is associated with decreased accumulation of its platinum (II) analogue, dichloro(D,L-trans)1,2-diaminocyclohexaneplatinum (II).
Topics: Animals; Antineoplastic Agents; Azides; Biological Transport; Carboplatin; Cell Line; Chromatography, High Pressure Liquid; Cisplatin; Drug Resistance, Neoplasm; Kinetics; Lymphoma, T-Cell; Mice; Organoplatinum Compounds; Sodium Azide; Sulfhydryl Compounds; Tumor Cells, Cultured | 1996 |
Preclinical assessment of carboplatin treatment efficacy in lung cancer by 18F-ICMT-11-positron emission tomography.
Topics: Animals; Antineoplastic Agents; Apoptosis; Azides; Carboplatin; Caspase 3; Caspase 7; Cell Death; Cell Line, Tumor; Disease Models, Animal; Drug Evaluation, Preclinical; Enzyme Activation; Female; Humans; Indoles; Lung Neoplasms; Positron-Emission Tomography; Xenograft Model Antitumor Assays | 2014 |
Development of a novel carboplatin like cytoplasmic trackable near infrared fluorophore conjugate via strain-promoted azide alkyne cycloaddition.
Topics: Antineoplastic Agents; Azides; Carboplatin; Cell Line, Tumor; Cell Survival; Click Chemistry; Cycloaddition Reaction; Cytoplasm; Humans; Platinum | 2018 |